TY - JOUR
T1 - Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients
AU - Yurchenko, Andrey A.
AU - Rajabi, Fatemeh
AU - Braz-Petta, Tirzah
AU - Fassihi, Hiva
AU - Lehmann, Alan
AU - Nishigori, Chikako
AU - Wang, Jinxin
AU - Padioleau, Ismael
AU - Gunbin, Konstantin
AU - Panunzi, Leonardo
AU - Morice-Picard, Fanny
AU - Laplante, Pierre
AU - Robert, Caroline
AU - Kannouche, Patricia L.
AU - Menck, Carlos F.M.
AU - Sarasin, Alain
AU - Nikolaev, Sergey I.
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12/1
Y1 - 2023/12/1
N2 - Xeroderma pigmentosum (XP) is a genetic disorder caused by mutations in genes of the Nucleotide Excision Repair (NER) pathway (groups A-G) or in Translesion Synthesis DNA polymerase η (V). XP is associated with an increased skin cancer risk, reaching, for some groups, several thousand-fold compared to the general population. Here, we analyze 38 skin cancer genomes from five XP groups. We find that the activity of NER determines heterogeneity of the mutation rates across skin cancer genomes and that transcription-coupled NER extends beyond the gene boundaries reducing the intergenic mutation rate. Mutational profile in XP-V tumors and experiments with POLH knockout cell line reveal the role of polymerase η in the error-free bypass of (i) rare TpG and TpA DNA lesions, (ii) 3’ nucleotides in pyrimidine dimers, and (iii) TpT photodimers. Our study unravels the genetic basis of skin cancer risk in XP and provides insights into the mechanisms reducing UV-induced mutagenesis in the general population.
AB - Xeroderma pigmentosum (XP) is a genetic disorder caused by mutations in genes of the Nucleotide Excision Repair (NER) pathway (groups A-G) or in Translesion Synthesis DNA polymerase η (V). XP is associated with an increased skin cancer risk, reaching, for some groups, several thousand-fold compared to the general population. Here, we analyze 38 skin cancer genomes from five XP groups. We find that the activity of NER determines heterogeneity of the mutation rates across skin cancer genomes and that transcription-coupled NER extends beyond the gene boundaries reducing the intergenic mutation rate. Mutational profile in XP-V tumors and experiments with POLH knockout cell line reveal the role of polymerase η in the error-free bypass of (i) rare TpG and TpA DNA lesions, (ii) 3’ nucleotides in pyrimidine dimers, and (iii) TpT photodimers. Our study unravels the genetic basis of skin cancer risk in XP and provides insights into the mechanisms reducing UV-induced mutagenesis in the general population.
UR - http://www.scopus.com/inward/record.url?scp=85159552387&partnerID=8YFLogxK
U2 - 10.1038/s41467-023-38311-0
DO - 10.1038/s41467-023-38311-0
M3 - Article
C2 - 37142601
AN - SCOPUS:85159552387
SN - 2041-1723
VL - 14
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 2561
ER -